Literature DB >> 24127305

Management of osteoarthritis in general practice in Australia.

Caroline A Brand1, Christopher Harrison, Joanne Tropea, Rana S Hinman, Helena Britt, Kim Bennell.   

Abstract

OBJECTIVE: To describe management of osteoarthritis (OA) of the hip (OA-hip) and knee (OA-knee) by Australian general practitioners (GPs).
METHODS: We analyzed data from the Bettering the Evaluation and Care of Health program, from April 1, 2005 to March 31, 2010. Patient and GP characteristics and encounter management data were extracted. Data were classified by the International Classification of Primary Care, version 2, and summarized using descriptive statistics and 95% confidence intervals around point estimates.
RESULTS: There were 489,900 GP encounters at which OA was managed (rate of 26.4 per 1,000 encounters). OA-hip was managed at a rate of 2.3 per 1,000 encounters (n = 1,106, 8.6% OA) and OA-knee at a rate of 6.2 per 1,000 (n = 3,058, 23.7% OA). The encounter management rate per 1,000 for OA-hip was higher among non-metropolitan dwellers (2.85 per 1,000 versus 1.97 per 1,000) and lower for non-English-speaking people (1.53 per 1,000 encounters versus 2.39 per 1,000). The rate for OA-knee was higher for non-English-speaking background (8.50 per 1,000 encounters versus 6.24 per 1,000) and lower among indigenous people (3.16 per 1,000 encounters versus 6.46 per 1,000). Referral to an orthopedic surgeon was the most frequently used nonpharmacologic management (OA-knee 17.4 per 100 contacts and OA-hip 17.7 per 100), followed by advice, education, and counselling. As first-line treatment, medication prescription rates (OA-knee 78.7 per 100 contacts and OA-hip 73.2 per 100) were substantially higher than rates of lifestyle management (OA-knee 20.7 per 100 contacts and OA-hip 14.8 per 100).
CONCLUSION: OA-hip and OA-knee encounters and management differ. Nonpharmacologic treatments as first-line management were low compared with pharmacologic management rates, and surgical referral rates were high. However, lack of longitudinal data limits definitive assessment of appropriateness of care.
Copyright © 2014 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2014        PMID: 24127305     DOI: 10.1002/acr.22197

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  46 in total

1.  Paracetamol versus placebo for knee and hip osteoarthritis.

Authors:  Amanda O Leopoldino; Gustavo C Machado; Paulo H Ferreira; Marina B Pinheiro; Richard Day; Andrew J McLachlan; David J Hunter; Manuela L Ferreira
Journal:  Cochrane Database Syst Rev       Date:  2019-02-25

2.  Demographic and Clinical Factors Associated With Nonsurgical Osteoarthritis Treatment Among Patients in Outpatient Clinics.

Authors:  Lauren M Abbate; Amy S Jeffreys; Cynthia J Coffman; Todd A Schwartz; Liubov Arbeeva; Leigh F Callahan; Nicole A Negbenebor; Wendy M Kohrt; Robert S Schwartz; Ernest Vina; Kelli D Allen
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-07-05       Impact factor: 4.794

3.  Misconceptions and the Acceptance of Evidence-based Nonsurgical Interventions for Knee Osteoarthritis. A Qualitative Study.

Authors:  Samantha Bunzli; Penny O'Brien; Darshini Ayton; Michelle Dowsey; Jane Gunn; Peter Choong; Jo-Anne Manski-Nankervis
Journal:  Clin Orthop Relat Res       Date:  2019-09       Impact factor: 4.176

4.  The Web-Based Osteoarthritis Management Resource My Joint Pain Improves Quality of Care: A Quasi-Experimental Study.

Authors:  Hema Umapathy; Kim Bennell; Chris Dickson; Fiona Dobson; Marlene Fransen; Graeme Jones; David J Hunter
Journal:  J Med Internet Res       Date:  2015-07-07       Impact factor: 5.428

5.  Australian GP management of osteoarthritis following the release of the RACGP guideline for the non-surgical management of hip and knee osteoarthritis.

Authors:  Martin Basedow; Helena Williams; E Michael Shanahan; William B Runciman; Adrian Esterman
Journal:  BMC Res Notes       Date:  2015-10-05

6.  High-throughput bone and cartilage micropellet manufacture, followed by assembly of micropellets into biphasic osteochondral tissue.

Authors:  Betul Kul Babur; Kathryn Futrega; William B Lott; Travis Jacob Klein; Justin Cooper-White; Michael Robert Doran
Journal:  Cell Tissue Res       Date:  2015-04-30       Impact factor: 5.249

7.  Variation in use of non-surgical treatments among osteoarthritis patients in orthopaedic practice in the Netherlands.

Authors:  Stefanie N Hofstede; Thea P M Vliet Vlieland; Cornelia H M van den Ende; Rob G H H Nelissen; Perla J Marang-van de Mheen; Leti van Bodegom-Vos
Journal:  BMJ Open       Date:  2015-09-09       Impact factor: 2.692

8.  The rapid manufacture of uniform composite multicellular-biomaterial micropellets, their assembly into macroscopic organized tissues, and potential applications in cartilage tissue engineering.

Authors:  Betul Kul Babur; Mahboubeh Kabiri; Travis Jacob Klein; William B Lott; Michael Robert Doran
Journal:  PLoS One       Date:  2015-05-28       Impact factor: 3.240

9.  The effect on knee-joint load of instruction in analgesic use compared with neuromuscular exercise in patients with knee osteoarthritis: study protocol for a randomized, single-blind, controlled trial (the EXERPHARMA trial).

Authors:  Brian Clausen; Anders Holsgaard-Larsen; Jens Søndergaard; Robin Christensen; Thomas P Andriacchi; Ewa M Roos
Journal:  Trials       Date:  2014-11-15       Impact factor: 2.279

10.  Clinic variation in recruitment metrics, patient characteristics and treatment use in a randomized clinical trial of osteoarthritis management.

Authors:  Kelli D Allen; Hayden B Bosworth; Ranee Chatterjee; Cynthia J Coffman; Leonor Corsino; Amy S Jeffreys; Eugene Z Oddone; Catherine Stanwyck; William S Yancy; Rowena J Dolor
Journal:  BMC Musculoskelet Disord       Date:  2014-12-06       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.